.webp)
Kailera Therapeutics appoints Jamie Coleman as Chief Commercial Officer to drive its global commercial strategy.
Kailera Therapeutics, Inc. - a clinical-stage biopharmaceutical company working on developing the next generation of therapies for obesity and its related conditions has announced the appointment of Jamie Coleman as its Chief Commercial Officer (CCO). In this new role, Coleman will help craft and drive Kailera's overall commercial strategy with a specific emphasis on the firm's advanced clinical-stage product candidates including KAI-9531, as the firm moves forward to start a global Phase 3 clinical program.
Jamie Coleman is joining Kailera from Eli Lilly, where she held key leadership positions, including Vice President, U.S. Brand Leader for Zepbound® an obesity treatment. With almost 25 years of experience in global healthcare brands, Coleman brings extensive experience in brand strategy, global commercial leadership and consumer marketing. She spent 17 years at Eli Lilly, where among other things, she spearheaded the launch and successful commercialization of some of the company's major products, including Zepbound®, Trulicity for type 2 diabetes, Jardiance for diabetes, and Lartruvo for the treatment of solid tumors.
Ron Renaud, President and CEO of Kailera, expressed excitement about Coleman joining the team, emphasizing her proven track record in launching blockbuster brands and leading high-performing teams. He noted that her leadership will be crucial as Kailera works to deliver next-generation therapies for patients suffering from obesity and related conditions.
Colella, who has a passion for addressing obesity as a major health challenge, was thrilled to join Kailera and support the company's mission of providing patient-centered solutions. She aims to utilize her experience in driving cross-functional collaboration and building impactful healthcare brands to drive Kailera's promising pipeline of therapies forward.
Coleman has an M.B.A. from the University of Chicago Booth School of Business and a B.B.A. from the University of Wisconsin, making her well qualified to lead Kailera's commercial strategy.
.webp)
